These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 14569416)

  • 1. Evaluation of the antiangiogenic effect of Taxol in a human epithelial ovarian carcinoma cell line.
    Hata K; Osaki M; Dhar DK; Nakayama K; Fujiwaki R; Ito H; Nagasue N; Miyazaki K
    Cancer Chemother Pharmacol; 2004 Jan; 53(1):68-74. PubMed ID: 14569416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the angopoietin-1, angopoietin-2, Tie2, and vascular endothelial growth factor gene in epithelial ovarian cancer.
    Hata K; Nakayama K; Fujiwaki R; Katabuchi H; Okamura H; Miyazaki K
    Gynecol Oncol; 2004 Apr; 93(1):215-22. PubMed ID: 15047239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
    Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
    Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
    Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases.
    Etoh T; Inoue H; Tanaka S; Barnard GF; Kitano S; Mori M
    Cancer Res; 2001 Mar; 61(5):2145-53. PubMed ID: 11280779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tumor suppressor gene (p53) on brain tumor angiogenesis and expression of angiogenic modulators.
    Tse V; Yung Y; Santarelli JG; Juan D; Hsiao M; Haas M; Harsh G; Silverberg G
    Anticancer Res; 2004; 24(1):1-10. PubMed ID: 15015569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis.
    Goede V; Schmidt T; Kimmina S; Kozian D; Augustin HG
    Lab Invest; 1998 Nov; 78(11):1385-94. PubMed ID: 9840613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiopoietin-1 is inversely related to thymidine phosphorylase expression in human breast cancer, indicating a role in vascular remodeling.
    Currie MJ; Gunningham SP; Han C; Scott PA; Robinson BA; Harris AL; Fox SB
    Clin Cancer Res; 2001 Apr; 7(4):918-27. PubMed ID: 11309342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of angiopoietin-2 and vascular endothelial growth factor in androgen-independent prostate cancer models.
    Tesan T; Gustavsson H; Welén K; Damber JE
    BJU Int; 2008 Sep; 102(8):1034-9. PubMed ID: 18489523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis gene expression profiling in xenograft models to study cellular interactions.
    Thijssen VL; Brandwijk RJ; Dings RP; Griffioen AW
    Exp Cell Res; 2004 Oct; 299(2):286-93. PubMed ID: 15350528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
    Guo Y; Wang S; Hoot DR; Clinton SK
    J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal regulation of angiopoietin-1 and angiopoietin-2 following myocardial infarction in the rat.
    Sandhu R; Teichert-Kuliszewska K; Nag S; Proteau G; Robb MJ; Campbell AI; Kuliszewski MA; Kutryk MJ; Stewart DJ
    Cardiovasc Res; 2004 Oct; 64(1):115-24. PubMed ID: 15364619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas.
    Eggert A; Ikegaki N; Kwiatkowski J; Zhao H; Brodeur GM; Himelstein BP
    Clin Cancer Res; 2000 May; 6(5):1900-8. PubMed ID: 10815914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of thymidine phosphorylase expression by Taxol does not enhance Furtulon sensitivity in a cisplatin-resistant human ovarian carcinoma cell line.
    Hata K; Osaki M; Kanasaki H; Nakayama K; Fujiwaki R; Ito H; Miyazaki K
    Anticancer Res; 2003; 23(2B):1525-31. PubMed ID: 12820419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic expression of ANG2 RNA in metastatic colorectal cancer.
    Ogawa M; Yamamoto H; Nagano H; Miyake Y; Sugita Y; Hata T; Kim BN; Ngan CY; Damdinsuren B; Ikenaga M; Ikeda M; Ohue M; Nakamori S; Sekimoto M; Sakon M; Matsuura N; Monden M
    Hepatology; 2004 Feb; 39(2):528-39. PubMed ID: 14768007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenic switch of angiopietins-Tie2 system and its prognostic value in bladder cancer.
    Szarvas T; Jäger T; Tötsch M; vom Dorp F; Kempkensteffen C; Kovalszky I; Romics I; Ergün S; Rübben H
    Clin Cancer Res; 2008 Dec; 14(24):8253-62. PubMed ID: 19088043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The angiogenic makeup of human hepatocellular carcinoma does not favor vascular endothelial growth factor/angiopoietin-driven sprouting neovascularization.
    Zeng W; Gouw AS; van den Heuvel MC; Zwiers PJ; Zondervan PE; Poppema S; Zhang N; Platteel I; de Jong KP; Molema G
    Hepatology; 2008 Nov; 48(5):1517-27. PubMed ID: 18924243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia.
    Hou HA; Chou WC; Lin LI; Tang JL; Tseng MH; Huang CF; Yao M; Chen CY; Tsay W; Tien HF
    Leuk Res; 2008 Jun; 32(6):904-12. PubMed ID: 17904634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
    Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I
    Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Down-regulation of vascular endothelial growth factor expression in ovarian cancer cell line SKOV3 by interferon-gamma].
    Lin FF; Chen HZ; Xie X; Ye DF
    Zhonghua Fu Chan Ke Za Zhi; 2003 Mar; 38(3):150-3, 3-1. PubMed ID: 12816689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.